We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$2B
AUM Growth
+$12.2M
Cap. Flow
-$123M
Cap. Flow %
-6.13%
Top 10 Hldgs %
36.44%
Holding
384
New
60
Increased
76
Reduced
187
Closed
58

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$39.4M
2
HPQ icon
HP
HPQ
+$34M
3
SO icon
Southern Company
SO
+$33.9M
4
CNC icon
Centene
CNC
+$33.7M
5
UGI icon
UGI
UGI
+$33M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$71.9M
2
LEA icon
Lear
LEA
+$42.1M
3
SLCA
U.S. SILICA HOLDINGS, INC.
SLCA
+$37.4M
4
FANG icon
Diamondback Energy
FANG
+$36.8M
5
LYB icon
LyondellBasell Industries
LYB
+$34.7M

Sector Composition

Rank Sector Weight
1 Healthcare 30.15%
2 Technology 21.65%
3 Industrials 12.91%
4 Utilities 10.27%
5 Consumer Staples 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLB icon
126
SLB Ltd
SLB
$73.6B
$811K 0.04%
9,493
-5,504
-37% -$506K
APC
127
DELISTED
Anadarko Petroleum
APC
$803K 0.04%
9,730
-200
-2% -$17.4K
MTD icon
128
Mettler-Toledo International
MTD
$28.6B
$799K 0.04%
2,642
-13
-0.5% -$3.57K
TARO
129
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$795K 0.04%
5,363
-1,477
-22% -$217K
KS
130
DELISTED
KapStone Paper and Pack Corp.
KS
$792K 0.04%
27,031
-417
-2% -$12.1K
LUX
131
DELISTED
Luxottica Group
LUX
$786K 0.04%
14,433
-75
-0.5% -$3.86K
COP icon
132
ConocoPhillips
COP
$147B
$775K 0.04%
11,223
+1,200
+12% +$83.8K
OHI icon
133
Omega Healthcare
OHI
$15.1B
$774K 0.04%
+19,804
New +$750K
TRGP icon
134
Targa Resources
TRGP
$58B
$770K 0.04%
7,262
-92
-1% -$10.7K
JLL icon
135
Jones Lang LaSalle
JLL
$16.3B
$762K 0.04%
+5,081
New +$701K
NVO
136
Novo Nordisk
NVO
$208B
$759K 0.04%
35,876
-168
-0.5% -$3.75K
CVX icon
137
Chevron
CVX
$392B
$754K 0.04%
6,723
+1,827
+37% +$208K
HUM icon
138
Humana
HUM
$43.7B
$753K 0.04%
5,242
-43
-0.8% -$5.88K
CBPO
139
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$750K 0.04%
+11,149
New +$691K
BT
140
DELISTED
BT Group plc (ADR)
BT
$741K 0.04%
23,898
-192
-0.8% -$5.87K
CSCO icon
141
Cisco
CSCO
$457B
$730K 0.04%
26,242
+1,068
+4% +$27.6K
WSBF icon
142
Waterstone Financial
WSBF
$370M
$725K 0.04%
55,166
-709
-1% -$8.69K
VTRS icon
143
Viatris
VTRS
$20.4B
$719K 0.04%
12,761
+1,265
+11% +$67.9K
APOG icon
144
Apogee Enterprises
APOG
$826M
$701K 0.04%
+16,554
New +$707K
EW icon
145
Edwards Lifesciences
EW
$49.6B
$695K 0.03%
+32,718
New +$657K
TDG icon
146
TransDigm Group
TDG
$70.2B
$693K 0.03%
3,530
-74
-2% -$14K
AMBA icon
147
Ambarella
AMBA
$3.77B
$686K 0.03%
+13,519
New +$632K
AFH
148
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$679K 0.03%
41,625
-337
-0.8% -$5.06K
ALXN
149
DELISTED
Alexion Pharmaceuticals
ALXN
$678K 0.03%
3,666
-77
-2% -$14.3K
MPWR icon
150
Monolithic Power Systems
MPWR
$70.1B
$676K 0.03%
13,588
-3,680
-21% -$165K
4 5
6
7 8

Similar funds

JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
RCIM
Red Cedar Investment Management Grand Rapids, Michigan $965M AUM 30.25% 1-Year Est. Return

Navellier & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Navellier & Associates held 384 positions worth $2B, up 0.62% from $1.99B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Navellier & Associates withdrew a net $123M in Q4 2014, closing 58 positions and reducing 187 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $71.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, Navellier & Associates opened a new position in HEALTH NET INC worth $42.8M.

  • Navellier & Associates's largest Q4 2014 buy was HEALTH NET INC: 799,779 shares worth $42.8M.
  • Navellier & Associates added most to Southern Company in Q4 2014, an estimated $33.9M increase.
  • Navellier & Associates's biggest Q4 2014 reduction was DuPont de Nemours, cutting an estimated $31.3M.
  • Navellier & Associates fully exited Thermo Fisher Scientific in Q4 2014, selling an estimated $71.9M.
  • Navellier & Associates's ten largest holdings make up 36% of its $2B portfolio in Q4 2014.
  • Navellier & Associates opened 60 new positions and closed 58 in Q4 2014.
  • Navellier & Associates's portfolio value rose 0.62% quarter-over-quarter to $2B.

Based on Navellier & Associates's 13F filing for Q4 2014, filed 2 Feb 2015.